Novo Nordisk Follows Lilly To Lower-Priced Insulin

 
• By David Wallace
  
Insulin
A drop in the price of insulin aspart will result from Novo Nordisk’s authorized generics • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation